Alpha Cognition (ACOG) Net Margin (2025 - 2026)

Alpha Cognition (ACOG) posted quarterly Net Margin of 245.48% for Q4 2025, down 429.07% quarter-over-quarter from 46.4% in Q3 2025.

Alpha Cognition (ACOG) Net Margin (2025 - 2026) Analysis & Trends

Alpha Cognition's Net Margin history runs 1 years deep, the most recent figure standing at 245.48% for Q4 2025.

In Q4 2025, Net Margin changed N/A year-over-year to 245.48%; the TTM figure through Dec 2025 stood at 202.24% (changed N/A YoY), while the FY2025 annual figure was 202.24%, changed N/A from the prior year.
Net Margin for Q4 2025 stood at 245.48%, down from 46.4% in the prior quarter.
The five-year high for Net Margin was 46.4% in Q3 2025, with the low at 632.75% in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Margin (Qtr)
1	Vertex Pharmaceuticals	139.88 Bn	132.03 Bn	2.84 Bn	32.99%
2	Regeneron Pharmaceuticals	86.62 Bn	78.62 Bn	3.93 Bn	30.23%
3	Argenx Se	65.28 Bn	60.10 Bn	1.37 Bn	31.16%
4	Moderna	61.39 Bn	56.25 Bn	52.00 Mn	-539.31%
5	BeOne Medicines	42.11 Bn	37.01 Bn	1.53 Bn	13.90%
6	Alnylam Pharmaceuticals	31.37 Bn	28.06 Bn	992.69 Mn	12.74%
7	BioNTech SE	28.76 Bn	10.37 Bn	668.28 Mn	-16.51%
8	Insmed	27.46 Bn	26.30 Bn	358.27 Mn	-3.12%
9	Royalty Pharma	27.24 Bn	26.41 Bn	-	12.09%
10	Alpha Cognition	210.12 Mn	168.68 Mn	5.70 Mn	-144.26%

Download Data